Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 15, 2025 • 2:00 AM ET

Date/Time Source News Release
05/20/2025 09:00 AM EDT Newsfile Hemostemix Presents at TERMIS 2025, Freiburg, Germany
05/12/2025 09:00 AM EDT Newsfile Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
05/08/2025 09:12 AM EDT Newsfile Hemostemix at Invest Stuttgart
04/23/2025 11:53 AM EDT Newsfile Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
03/17/2025 10:28 AM EDT Newsfile Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
03/14/2025 08:35 AM EDT GlobeNewswire Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
03/12/2025 01:12 PM EDT GlobeNewswire Life Sciences Investor Forum Agenda Announced for March 13th
03/06/2025 07:30 AM EST Newsfile Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
03/05/2025 07:45 AM EST Newsfile Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
02/20/2025 06:05 AM EST Newsfile RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies
Page

Additional News

As of June 15, 2025 • 2:00 AM ET

Date/Time Source News Release
01/06/2025 09:37 AM EST SeekingAlpha Hemostemix announces incorporation of Hemostemix PR
06/03/2024 01:23 PM EDT y%wire Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear
09/28/2023 07:53 AM EDT SeekingAlpha Hemostemix announces $325,125 private placement
06/02/2023 06:18 AM EDT SeekingAlpha Hemostemix to raise $1.2M through private placement of units
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.